Bio Rad Laboratories (BIO) Aktsia Kursus

Bio Rad Laboratories Kursus

NYSE·SULETUD
358,90
​
Turg suletud

Käive kasvas 3,8 % aastas viimase 19 aasta jooksul 2,58 B USD-ni. Kasum aktsia kohta kasvas 11,1 % aastas viimase 19 aasta jooksul. Bio Rad Laboratories netomarginaal on nüüd 29,4 %, langenud 145,6 %-lt mõni aasta tagasi. Analüütikute hinnasihi mediaan on 350,00 USD, st alla praegust hinda 2,5 %. 10 analüütikust 5 soovitab osta — üldine konsensus on Osta.

Bio Rad Laboratories aktsiahinnad

Hangi need andmed Eulerpool API kaudu

100 000 päringut/kuus tasuta · krediitkaarti pole

Bio Rad Laboratories ärimudel ja aktsia analüüs

Bio-Rad Laboratories Inc. on juhtiv ettevõte teadusuuringute valdkonnas, mis asub California osariigis Hercules's. Ettevõtte asutasid 1952. aastal kaks venda ja sellest ajast on see arenenud rahvusvaheliseks ettevõtteks, millel üle maailma töötab üle 8000 inimese. Bio-Radi filiaalid asuvad rohkem kui 100 riigis ja tema tooteid kasutatakse biotehnoloogias, farmaatsiatööstuses ning toiduainetööstuses. Ajalugu Bio-Radi asutasid 1952. aastal paar David ja Alice Schwartz. Nad alustasid veregruppide seroloogiliste testide tootmisega ja laiendasid hiljem oma tootevalikut immunokeemiliste ainete, elektrokeerimisseadmete ja antikehadega. 1970. aastatel arendas Bio-Rad välja esimese kommersiaalse valgu A puhastussüsteemi, mis on tänase päevani oluline komponent valgusuuringutes. Ärimudel Bio-Radi ärimudel keskendub kvaliteetsete toodete ja teenuste pakkumisele, et toetada kliente nende teadusuuringutes. Ettevõttel on erinevad osakonnad nagu eluteaduste uurimine, kliiniline diagnostika ja eluteaduste haridus, mis pakuvad tooteid ja lahendusi teadlastele, uurijatele ja diagnostikutele. Eluteaduste uurimine Eluteaduste uurimise osakond pakub laia valikut tooteid ja teenuseid bioloogilisteks uuringuteks. See hõlmab PCR-süsteeme, elektrokeerimisseadmeid, antikehi, valke, rakulugejaid ja palju muud. Bio-Radi tooteid kasutavad teadlased ja uurijad üle maailma, et paremini mõista elu keerukust ja haiguste mehhanisme. Kliiniline diagnostika Bio-Radi kliinilise diagnostika osakond pakub laia spektriga diagnostilisi tooteid ja lahendusi haiglatele, laboritele ja meditsiiniasutustele. Ettevõte pakub kliinilisi diagnostikaseadmeid, reagentse, testimissüsteeme ja tarkvara, et toetada diagnostilist protsessi. Eluteaduste haridus Eluteaduste hariduse osakond pakub innovaatilisi ja interaktiivseid õppe- ja õppematerjale teaduslikeks uuringuteks õpetajatele, professoritele ja üliõpilastele. Bio-Radi tooted ja lahendused aitavad paremini mõista elu keerukust ja haiguste mehhanisme bioloogia, keemia ja füüsika valdkondades. Tooted Bio-Rad pakub laia valikut tooteid ja lahendusi uurimiseks ja diagnostikaks. Nende hulka kuuluvad muu hulgas: PCR-süsteemid: Bio-Rad pakub erinevaid PCR-süsteeme, mis aitavad teadlastel ja diagnostikutel amplifitseerida ja analüüsida DNA-d. Süsteemid on väga täpsed ja annavad usaldusväärseid tulemusi. Valgud ja antikehad: Bio-Rad pakub laia valikut valke ja antikehi uurimiseks ja diagnostikaks. Tooteid sisaldavad erinevat tüüpi valke ja antikehi, mida on vaja valkude funktsioonide ja interaktsioonide analüüsimiseks. Elektrokeerimisseadmed: Bio-Rad pakub erinevaid elektrokeerimisseadmeid, mis mängivad olulist rolli uurimises ja diagnostikas. Tooteid sisaldavad geeli elektrokeerimissüsteeme, Western blot süsteeme ja seadmeid valkude analüüsimiseks. Kliiniline diagnostika: Bio-Rad pakub laia valikut diagnostilisi tooteid haiglatele, laboritele ja meditsiiniasutustele. Nende hulka kuuluvad immunoassay tooted, veregrupi seroloogilised testid ja seadmed nakkushaiguste diagnoosimiseks. Kokkuvõtteks on Bio-Rad Laboratories Inc. juhtiv ettevõte teadusuuringute valdkonnas. Ettevõte pakub laia valikut tooteid ja lahendusi uurimiseks ja diagnostikaks, toetades teadlasi, uurijaid ja diagnostikuteid üle maailma elu keerukuse avastamisel ja haiguste paremaks mõistmiseks.

Korduma kippuvad küsimused Bio Rad Laboratories aktsia kohta

The business model of Bio Rad Laboratories Inc. revolves around refining and providing innovative solutions for the life science research and diagnostic markets. As a leading global provider of products and systems, Bio Rad Laboratories Inc. focuses on developing and manufacturing a wide range of specialized products. These include instruments, reagents, consumables, software, and services that cater to medical diagnostics, scientific research, and biopharmaceutical production. By continuously investing in research and development, Bio Rad Laboratories Inc. aims to meet the diverse needs of its customers, drive scientific advancements, and improve patient outcomes worldwide.

Bio Rad Laboratories Inc operates primarily in the Life Sciences and Clinical Diagnostics industries. As a leading global provider of specialty diagnostic solutions, Bio Rad offers a wide range of products and services for scientific research and healthcare diagnostics. The company specializes in developing and manufacturing instruments, reagents, software, and consumables for applications in life science research, clinical laboratories, and pharmaceutical production. With a focus on advancing scientific discovery and improving patient healthcare, Bio Rad Laboratories Inc plays a crucial role in the fields of molecular biology, genomics, proteomics, and more.

Some of the main competitors of Bio Rad Laboratories Inc in the market include Thermo Fisher Scientific Inc, PerkinElmer Inc, and Illumina Inc.

Bio Rad Laboratories Inc, established in 1952, is a global leader in life science research and clinical diagnostics. The company's rich history spans over several decades, during which it has consistently provided innovative solutions to scientists and healthcare professionals. Bio Rad initially focused on the development of specialized products for the growing field of biochemical research, and later expanded into medical diagnostics and life science technologies. Today, Bio Rad continues to deliver cutting-edge technology, spanning areas such as genomics, proteomics, cell biology, food safety, and more. With a commitment to excellence and advancements in healthcare, Bio Rad Laboratories Inc remains a trusted name in the scientific community.

Bio Rad Laboratories Inc has accomplished several significant milestones. From its inception in 1952, the company has become a global leader in life science research and clinical diagnostics. One noteworthy achievement is the development of ground-breaking products, such as the first digital imaging system for electrophoresis analysis, which revolutionized the field. Bio Rad also played a crucial role in advancing HIV/AIDS diagnostics and monitoring through the introduction of reliable testing systems. Additionally, the company's continuous dedication to innovation has led to expansions in various areas, including food safety and quality control, further strengthening its position as a trusted provider of scientific solutions across industries. Bio Rad Laboratories Inc remains committed to driving advancements and enhancing scientific research globally.

Bio Rad Laboratories Inc is primarily present in the United States, with its headquarters located in Hercules, California. Aside from its domestic presence, Bio Rad operates internationally in various countries and regions. This includes Europe (with offices in the United Kingdom, France, Germany, and other countries), Asia-Pacific (including Japan, China, Korea, and Australia), Latin America, and Canada. With its extensive global footprint, Bio Rad Laboratories Inc continues to expand its reach and serve customers worldwide in the life sciences and clinical diagnostics industries.

Bio Rad Laboratories Inc represents a strong set of values and a dedicated corporate philosophy. The company is committed to providing innovative solutions and high-quality products in the life sciences and clinical diagnostics fields. Bio Rad prioritizes excellence, integrity, and teamwork in all its endeavors. With a focus on customer satisfaction, Bio Rad strives to deliver superior value and support to its clients. The company's relentless dedication to scientific advancement and commitment to ethical and responsible business practices contribute to its reputable standing in the industry.

Analüütikud määravad Bio Rad Laboratories aktsiale keskmiseks hinnasihi 350,00 USD (mediaan: 350,00 USD), mis on −4,8 % viimase hinna suhtes. Konsensus põhineb 10 analüütiku hinnangul.

10 analüütikut hindavad praegu Bio Rad Laboratories aktsiat: 5 soovitab osta, 4 hoida ja 1 müüa. 2026. aastaks ootavad analüütikud, et Bio Rad Laboratories teenib tulu 2,59 B USD ja kasumit aktsia kohta 10,43 USD.

Praeguse kursiga kaubeldakse Bio Rad Laboratories aktsiaga 326,87 EUR (358,90 USD) juures.

Bio Rad Laboratories aktsia (BIO) on noteeritud 6 börsil, sh: NYSE (BIO), SIX (Zürich) (BUWA.SW), XETRA (BUWA.DE), Frankfurt (BUWA.F), München (BUWA.MU), Düsseldorf (BUWA.DU).

Bio Rad Laboratories Inc is a globally operating company in the field of life science research, diagnostics, and biopharmaceuticals. The company offers a wide range of innovative products and services for research institutions, biotechnology and pharmaceutical companies, as well as customers in clinical diagnostics. The business strategy of Bio Rad Laboratories is based on three pillars: product innovation, diversification, and global expansion. The company continuously invests in research and development to develop new products and services that meet the needs of its customers. Thanks to the diversification of its product lines, Bio Rad Laboratories is able to expand in various areas of life sciences and address a wide spectrum of customers. The company is divided into six main business areas: 1. Life Science Research Bio Rad Laboratories offers a comprehensive range of life science research products for research in genomics, proteomics, cell biology, and immunology. Products include DNA isolation kits, PCR reagents, protein separation systems, and antibody solutions. 2. Diagnostics Bio Rad Laboratories is a leading provider of in vitro diagnostics and QC/QA products. The company offers diagnostic products for clinical chemistry, hematology, immunology, and microbiology. 3. Biopharma Bio Rad Laboratories offers a wide range of solutions for biopharmaceuticals, including chromatography columns, protein purification systems, and analysis equipment. 4. Food Science Bio Rad Laboratories offers products for food quality assurance. This includes products for the identification of contaminants in food, such as salmonella, E. coli, and other bacterial contaminations, as well as for testing the nutrient quality in food. 5. Process Separations Bio Rad Laboratories offers a comprehensive range of chromatography columns and accessories used for downstream purification of proteins and other biomolecules in biopharmaceuticals and the food industry. 6. Digital Biology Bio Rad Laboratories offers solutions for digital PCR analysis with its droplet digital PCR technology. This technology allows for the quantification of nucleic acids on an absolute basis and can be used in numerous applications in research and diagnostics. The company also offers software solutions that simplify and standardize data recording and analysis in laboratory tests. The offered software solutions include laboratory information management systems (LIMS), chromatography software, and data analysis tools. Bio Rad Laboratories' customers include research institutions, biotechnology and pharmaceutical companies, as well as customers in clinical diagnostics. The company's products and services are sold in over 100 countries worldwide. In conclusion, Bio Rad Laboratories offers a wide portfolio of products and services in the field of life science research, diagnostics, and biopharmaceuticals. The company pursues a business strategy based on product innovation, diversification, and global expansion. Thanks to the wide range of products and services designed for different business areas, Bio Rad Laboratories is able to serve a broad spectrum of customers worldwide.

oodatav Bio Rad Laboratories käive on 2,59 B USD. See näitaja põhineb praegusel finantsandmetel ja peegeldab ettevõtte äritulemuseid.

oodatav Bio Rad Laboratories kasum on 281,67 M USD. Netokasum peegeldab ettevõtte kasumlikkust pärast kõigi kulude mahaarvamist.

Võrdlusarvud hinna ja kasumiga (P/E) Bio Rad Laboratories jaoks on praegu 34,42. P/E-suhtarv võrdleb praegust aktsiahinnad kasumiga aktsia kohta ja aitab investoritel hinnata Bio Rad Laboratories aktsia väärtust.

Kursuse ja müügimahu suhe (P/S) Bio Rad Laboratories jaoks on praegu 3,75. P/S-suhtarv võrdleb börsikapitalisatsooni aastase tuluga ja teenib hindamismõõdikuna Bio Rad Laboratories aktsia jaoks.

Eulpooli kvaliteedinäitaja Bio Rad Laboratories jaoks on 1/10.

Bio Rad Laboratories ISIN on US0905722072. ISIN (rahvusvaheline väärtpaberi identifitseerimise number) on väärtpaberite globaalne unikaalne tuvastaja.

Bio Rad Laboratories WKN on 865406. WKN (Wertpapierkennnummer) on kuuekohaline saksa väärtpaberi identifitseerimise number.

Bio Rad Laboratories ticker on BIO. Ticker-sümbol kasutatakse Bio Rad Laboratories aktsiate kauplemiseks börsil.

Õiglane väärtusTerminal
301,48 USD
Üle-/alahinnangTerminal
Õiglaselt hinnatakse
Tööstus
Eluteaduste tööriistad ja teenused
Aktsiate arv
Töötajad
Tulu töötaja kohta
346 738,26 USD
Tulukasvu keskmine 5 aastat
EBIT kasvu keskmine 5 aastat
Puhaskasumi kasvu keskmine 5 aastat
Veebisait bio-rad.com
Valuuta
USD
Börsi noteerimise algus
22. mai 1981
ISIN
US0905722072
CUSIP
090572207
SEDOL
2098508
Turukapitalisatsioon
10,13 B USDLarge Cap
52-nädala vahemik
PEG
1,52
P/E suhe
P/E e 2026
35,95
P/E e 2027
34,23
P/E e 2028
30,22
P/E e 2029
27,05
P/E e 2030
24,05
P/S
P/S e
3,75
EV/EBIT
41,13
P/B suhe
1,36
ROE (omakapitali tootlus)
ROA (varatootlus)
ROCE (kasutatud kapitali tootlus)
ROIC (investeeritud kapitali tootlus)
8,46 %
Viimati värskendatud 21. nov 2026, 10:09

Bio Rad Laboratories Börsiticker

DÜSSELDORF · BUWA.DUFRANKFURT · BUWA.FMÜNCHEN · BUWA.MUNEW YORK · BIOSIX · BUWA.SWXETRA · BUWA.DE

Bio Rad Laboratories FIGI

BUWA:GR · BBG000C08SF9BUWA:GF · BBG000C08SN0BUWA:GD · BBG000C08T58BUWA:GS · BBG000C08TR4BUWA:GM · BBG000C08V62BUWA:GB · BBG000C08VJ8BIO:US · BBG000DY28W5BIO:UA · BBG000DY29F2BIO:UC · BBG000DY3CF4BIO:UN · BBG000DY3DH0BIO:UP · BBG000DY3F58BIO:UB · BBG000DY3G83